Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-25-028259
Filing Date
2025-03-26
Accepted
2025-03-26 16:30:23
Documents
3
Period of Report
2025-03-26

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm258932d5_6k.htm 6-K 15764
2 EXHIBIT 5.1 tm258932d5_ex5-1.htm EX-5.1 31198
3 GRAPHIC tm258932d5_ex5-1img001.jpg GRAPHIC 7134
  Complete submission text file 0001104659-25-028259.txt   57978
Mailing Address DR NEERGAARDS VEJ 5F HOERSHOLM G7 2970
Business Address DR NEERGAARDS VEJ 5F HOERSHOLM G7 2970 4552656554
Evaxion Biotech A/S (Filer) CIK: 0001828253 (see all company filings)

EIN.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39950 | Film No.: 25773686
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)